ALGN
Get informed when a big investor buys or sells
+ FollowOvervalued by 36.1% based on the discounted cash flow analysis.
| Market cap | $10.22 Billion |
|---|---|
| Enterprise Value | $10.46 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $5.66 |
| Beta | 1.67 |
| Outstanding Shares | 71,460,000 |
| P/E Ratio | 24.78 |
|---|---|
| PEG | -189.24 |
| Price to Sales | 2.53 |
| Price to Book Ratio | 2.45 |
| Enterprise Value to Revenue | 2.53 |
| Enterprise Value to EBIT | 18.31 |
| Enterprise Value to Net Income | 25 |
| Total Debt to Enterprise | 0.13 |
| Debt to Equity | 0.32 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 133.57% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 0.11%▼ 102.66% |
|---|---|
| Total Invested | $10.99M▼ 99.91% |
| Investors Holding | 17▼ 692.00% |
No data
Align Technology, Inc., a prominent medical device company, is dedicated to developing, producing, and commercializing innovative solutions for dental professionals. Its core offerings include the well-known Invisalign clear aligner syst...